Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — February 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 9, 2026
Sale
Shares
75
Price
$780.06
Total Value
$58.50K
Shares Held After
4,533
% of Holdings
1.6%
Feb 9, 2026
Sale
Shares
205
Price
$779.56
Total Value
$159.81K
Shares Held After
4,608
% of Holdings
4.3%
Feb 9, 2026
Sale
Shares
563
Price
$778.35
Total Value
$438.21K
Shares Held After
4,813
% of Holdings
10.5%
Feb 9, 2026
Sale
Shares
391
Price
$777.51
Total Value
$304.01K
Shares Held After
5,376
% of Holdings
6.8%
Feb 9, 2026
Sale
Shares
521
Price
$776.43
Total Value
$404.52K
Shares Held After
5,767
% of Holdings
8.3%
Feb 9, 2026
Sale
Shares
20
Price
$775.95
Total Value
$15.52K
Shares Held After
6,288
% of Holdings
0.3%

ILLUMINA, INC. (ILMN)

Gottlieb Scott — Director
Feb 9, 2026
Purchase
Shares
200
Price
$117.81
Total Value
$23.56K
Shares Held After
12,723
% of Holdings
1.6%
Feb 9, 2026
Purchase
Shares
115,000
Price
$16.00
Total Value
$1.84M
Shares Held After
251,427
% of Holdings
45.7%
Feb 9, 2026
Purchase
Shares
20,000
Price
$16.00
Total Value
$320.00K
Shares Held After
25,450
% of Holdings
78.6%
Feb 9, 2026
Purchase
Shares
312,500
Price
$16.00
Total Value
$5.00M
Shares Held After
2,187,513
% of Holdings
14.3%

Entera Bio Ltd. (ENTX)

Ellis Sean — Director
Feb 9, 2026
Purchase
Shares
18,000
Price
$1.24
Total Value
$22.32K
Shares Held After
178,098
% of Holdings
10.1%

Entera Bio Ltd. (ENTX)

Rubin Steven D — Director
Feb 9, 2026
Purchase
Shares
10,000
Price
$1.20
Total Value
$12.00K
Shares Held After
10,000
% of Holdings
100.0%
Feb 9, 2026
Sale
Shares
889
Price
$2.39
Total Value
$2.13K
Shares Held After
79,133
% of Holdings
1.1%

Zentalis Pharmaceuticals, Inc. (ZNTL)

Bruns Ingmar — Chief Medical Officer
Feb 9, 2026
Sale
Shares
335
Price
$2.39
Total Value
$801.62
Shares Held After
33,332
% of Holdings
1.0%
Feb 9, 2026
Sale
Shares
3,379
Price
$2.39
Total Value
$8.09K
Shares Held After
153,400
% of Holdings
2.2%
Feb 9, 2026
Sale
Shares
12,840
Price
$3.78
Total Value
$48.57K
Shares Held After
962,097
% of Holdings
1.3%

RAPID MICRO BIOSYSTEMS, INC. (RPID)

WIRTJES SEAN M — CHIEF FINANCIAL OFFICER
Feb 9, 2026
Sale
Shares
6,027
Price
$3.78
Total Value
$22.80K
Shares Held After
483,928
% of Holdings
1.2%

RAPID MICRO BIOSYSTEMS, INC. (RPID)

Wilson John J. Addington — CHIEF OPERATING OFFICER
Feb 9, 2026
Sale
Shares
4,610
Price
$3.78
Total Value
$17.44K
Shares Held After
257,768
% of Holdings
1.8%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
7,875
Price
$474.65
Total Value
$3.74M
Shares Held After
0
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
14,625
Price
$474.65
Total Value
$6.94M
Shares Held After
0
% of Holdings
100.0%

ACADIA PHARMACEUTICALS INC (ACAD)

Rhodes Jennifer J — EVP, CHIEF LEGAL OFFICER, SEC
Feb 9, 2026
Sale
Shares
6,950
Price
$23.38
Total Value
$162.49K
Shares Held After
7,609
% of Holdings
47.7%
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
Feb 9, 2026
Purchase
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
Feb 9, 2026
Sale
Shares
14,625
Price
$8.56
Total Value
$125.19K
Shares Held After
387,225
% of Holdings
3.6%

Biogen Inc. (BIIB)

Singhal Priya — Head of Development
Feb 9, 2026
Sale
Shares
2,660
Price
$199.83
Total Value
$531.55K
Shares Held After
8,043
% of Holdings
24.9%
Feb 9, 2026
Sale
Shares
88
Price
$275.53
Total Value
$24.25K
Shares Held After
2,869
% of Holdings
3.0%

RESMED INC (RMD)

Farrell Michael J. — Director
Feb 9, 2026
Sale
Shares
4,991
Price
$273.78
Total Value
$1.37M
Shares Held After
466,223
% of Holdings
1.1%
Feb 9, 2026
Sale
Shares
17,159
Price
$21.03
Total Value
$360.82K
Shares Held After
491,690
% of Holdings
3.4%

Syndax Pharmaceuticals, Inc. (SNDX)

Goldan Keith A. — Chief Financial Officer
Feb 9, 2026
Sale
Shares
3,410
Price
$21.03
Total Value
$71.71K
Shares Held After
140,429
% of Holdings
2.4%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Feb 9, 2026
Sale
Shares
14,261
Price
$16.66
Total Value
$237.62K
Shares Held After
42,749
% of Holdings
25.0%
Feb 9, 2026
Sale
Shares
100
Price
$198.00
Total Value
$19.80K
Shares Held After
2,900
% of Holdings
3.3%
Feb 9, 2026
Sale
Shares
375
Price
$198.00
Total Value
$74.25K
Shares Held After
22,852
% of Holdings
1.6%

Merck & Co., Inc. (MRK)

Zachary Jennifer — EVP, General Counsel
Feb 9, 2026
Sale
Shares
38,835
Price
$119.15
Total Value
$4.63M
Shares Held After
68,916
% of Holdings
36.0%

Merck & Co., Inc. (MRK)

Zachary Jennifer — EVP, General Counsel
Feb 9, 2026
Sale
Shares
56,792
Price
$119.15
Total Value
$6.77M
Shares Held After
68,916
% of Holdings
45.2%

Merck & Co., Inc. (MRK)

Zachary Jennifer — EVP, General Counsel
Feb 9, 2026
Sale
Shares
25,946
Price
$119.15
Total Value
$3.09M
Shares Held After
68,916
% of Holdings
27.4%

Merck & Co., Inc. (MRK)

Guindo Chirfi — Chief Marketing Officer
Feb 9, 2026
Sale
Shares
10,000
Price
$118.41
Total Value
$1.18M
Shares Held After
70,615
% of Holdings
12.4%
Feb 6, 2026
Purchase
Shares
194
Price
$9.86
Total Value
$1.91K
Shares Held After
156,957
% of Holdings
0.1%
Feb 6, 2026
Sale
Shares
7,866
Price
$2.43
Total Value
$19.11K
Shares Held After
80,022
% of Holdings
9.0%

Zentalis Pharmaceuticals, Inc. (ZNTL)

Bruns Ingmar — Chief Medical Officer
Feb 6, 2026
Sale
Shares
2,962
Price
$2.43
Total Value
$7.20K
Shares Held After
33,667
% of Holdings
8.1%
Feb 6, 2026
Sale
Shares
29,951
Price
$2.43
Total Value
$72.77K
Shares Held After
156,779
% of Holdings
16.0%

Cingulate Inc. (CING)

Brams Matthew — EVP and Chief Medical Officer
Feb 6, 2026
Purchase
Shares
1,946
Price
$5.04
Total Value
$9.81K
Shares Held After
4,656
% of Holdings
41.8%
Feb 6, 2026
Purchase
Shares
6,809
Price
$5.04
Total Value
$34.32K
Shares Held After
10,175
% of Holdings
66.9%

Cingulate Inc. (CING)

Callahan Jennifer L. — SVP and CFO
Feb 6, 2026
Purchase
Shares
4,864
Price
$5.04
Total Value
$24.51K
Shares Held After
5,059
% of Holdings
96.1%

Cingulate Inc. (CING)

Werth Peter J. — Director
Feb 6, 2026
Purchase
Shares
19,455
Price
$5.04
Total Value
$98.05K
Shares Held After
117,449
% of Holdings
16.6%

Enliven Therapeutics, Inc. (ELVN)

Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Feb 6, 2026
Sale
Shares
5,000
Price
$29.04
Total Value
$145.22K
Shares Held After
740,188
% of Holdings
0.7%
Feb 6, 2026
Sale
Shares
29,430
Price
$85.79
Total Value
$2.52M
Shares Held After
254,497
% of Holdings
10.4%
Feb 6, 2026
Sale
Shares
4,000
Price
$229.72
Total Value
$918.88K
Shares Held After
28,264
% of Holdings
12.4%

Spero Therapeutics, Inc. (SPRO)

Keutzer Timothy — Chief Operating Officer
Feb 6, 2026
Sale
Shares
18,652
Price
$2.36
Total Value
$44.02K
Shares Held After
742,506
% of Holdings
2.5%

Spero Therapeutics, Inc. (SPRO)

Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Feb 6, 2026
Sale
Shares
50,816
Price
$2.36
Total Value
$119.93K
Shares Held After
1,012,091
% of Holdings
4.8%

Spero Therapeutics, Inc. (SPRO)

Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Feb 6, 2026
Sale
Shares
37,101
Price
$2.36
Total Value
$87.56K
Shares Held After
1,062,907
% of Holdings
3.4%
Version: v26.3.29